Disc Medicine
Latest round
- Series B
Last raised
- Sep 2021
Total raised
- $140M
Investors
- 11
About Disc Medicine
, Disc Medicine, Inc. operates as a biopharmaceutical company that provides advanced therapies for hematologic diseases to transform scientific discoveries into life-saving treatments for patients. In June 2024, Disc Medicine, Inc.94 million shares of common stock at USD 36 per share.D. The firm trades on Nasdaq under the ticker symbol IRON. The company provides a wide range of therapies for rare genetic disorders, blood cancers, and chronic diseases affecting millions. Additionally, the firm also provides services such as clinical trials and disease management solutions.
Who invested in Disc Medicine
11 investors across 2 rounds
See all investors in Disc Medicine
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Disc Medicine
Who invested in Disc Medicine?
Disc Medicine has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Disc Medicine raised?
Disc Medicine has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Disc Medicine last raise money?
Disc Medicine's most recent round on record is a Series B, in Sep 2021.
What does Disc Medicine do?
Disc Medicine is a biotechnology company.
Where is Disc Medicine headquartered?
Disc Medicine is headquartered in Watertown, US.
Which VCs invest in companies like Disc Medicine?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Disc Medicine's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Disc Medicine? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.